Gatifloxacin
4 NDCs across 4 manufacturers|3 Generic,1 Brand
Gatifloxacin is used to treat bronchitis, bacterial conjunctivitis, cystitis, escherichia coli infections, gonorrhea and haemophilus infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 28, 2003, and the first generic was approved Aug 19, 2011. In 2024, Medicare Part D spent $1 million on Gatifloxacin across 29,000 claims for 19,000 beneficiaries.
Gatifloxacin is available as 4 NDCs from 4 manufacturers (3 generic, 1 brand), with NADAC prices from $8.85 to $67.38 per ML — the most expensive product costs about 7.6× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
3G / 1B
Manufacturers
4
competing in market
Price Spread
$8.85 – $67.38
per ML
7d Activity
avg +8.2% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Allergan, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Quinolone Antimicrobial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing GATIFLOXACIN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZYMAXID 0.5% EYE DROPS | $67.3765 per ML | — |
GATIFLOXACIN 0.5% EYE DROPS | $12.0110 per ML | — |
GATIFLOXACIN 0.5% EYE DROPS | $8.8549 per ML | +8.22% |
GATIFLOXACIN 0.5% EYE DROPS | $8.8549 per ML | +8.22% |
Frequently Asked Questions
What is Gatifloxacin used to treat?
Gatifloxacin is used to treat bronchitis, bacterial conjunctivitis, cystitis, escherichia coli infections, gonorrhea and haemophilus infections, per the National Library of Medicine's MED-RT classification.
When did Gatifloxacin become available as a generic?
FDA approved the first generic Gatifloxacin (ANDA) on Aug 19, 2011.
How much does Medicare spend on Gatifloxacin?
In 2024, Medicare Part D spent $1 million on Gatifloxacin across 29,000 claims for 19,000 beneficiaries.
How many Gatifloxacin products are on the market?
The Gatifloxacin drug market contains 4 NDCs from 4 manufacturers — 3 generic and 1 brand product.
What is the price range for Gatifloxacin?
NADAC reference prices for Gatifloxacin range from $8.8549 to $67.3765 per ML — the most expensive product costs about 7.6× the cheapest.
Is generic Gatifloxacin cheaper than brand?
The average generic NADAC for Gatifloxacin is $9.9069 per ML, versus $67.3765 for brand-labeled products — brand versions average about 6.8× the generic price.
Which manufacturers make Gatifloxacin?
4 manufacturers list Gatifloxacin in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (1), Pacific Pharma, Inc. (1), Sandoz Inc. (1), Leading Pharma, LLC (1).
How has the price of Gatifloxacin changed recently?
Over the past 7 days, 2 Gatifloxacin NDCs rose and 0 fell, with a market-wide average change of +8.2%.